Etiometry has received a “Top Abstract” award at the PCICS International Meeting for “Using a High-Fidelity Physiologic Monitoring System to Evaluate a Clinical Protocol for Post-Operative Single Ventricle Congenital Heart Disease”.

The abstract illustrates the tremendous value that high-fidelity data capture brings to the evaluation of the effectiveness of clinical guidelines. It summarizes the results of a joint study between Boston Children’s Hospital and Etiometry that evaluated the use of the FDA-cleared Etiometry T3 Visualization & Data Aggregation software to track and record a patient’s physiological state for the purpose of assessing compliance to a clinical protocol as it relates to outcomes.

The lead author was Dr. Michael Goldsmith, a pediatric cardiologist at Boston Children’s Hospital, and it was co-authored by Boston Children’s Hospital Pediatric Cardiac Intensivists Dr. Joshua Salvin and Dr. John Kheir as well as myself and Etiometry CEO Evan Butler.

Previously clinical protocols and guidelines in the ICU have been mostly evaluated based on their effect on outcomes—without a clear understanding of protocol-compliance or the potential consequence of protocol non-compliance. In particular, the abstract demonstrates the evaluation of a protocol for the care of babies post palliation of a rare congenital heart defect.

Our Etiometry Platform provides novel insight into the effect of guidelines on clinical practice by capturing objective and clear evidence of how patient management is affected by introducing a new standard of care. If you’d like to learn more about this research, please send an email to info@etiometry.com.

Share this post!

Tags: , , , ,

Give Us Feedback